AMR NEWS: Your Global Source for the Latest AMR Insights and Publications!

Search for:

Home » _News » Smart Innovations » Page 21

AMR news related to Smart Innovations

For scientists, researchers, and innovators committed to staying at the forefront of antimicrobial resistance, AMR Insights provides the most comprehensive, up-to-date overview of global news and breakthroughs. Access cutting-edge research, expert insights, and the latest developments to fuel your work and accelerate progress in the fight against AMR.

IDSA describes AMR challenges, answers in congressional testimony

BactiVac receives research award at the prestigious Antibiotic Guardian Awards 2019

New ‘bacteria-phobic’ material could stop the spread of superbugs in hospitals

Personalized Health Approach To Antimicrobial Resistance Awarded £3.54 Million

Appili Therapeutics Signs $3M USD Grant Contract with the United States Department of Defense to Develop Antibiotics that Target Superbugs

Manchester BRC receives £4.4M investment to fight the growing threat of antibiotic resistance

UK: In the age of AMR, does a nationalised drug company make sense? The case for and against

Widely-available antibiotics could be used in the treatment of ‘superbug’ MRSA

Antimicrobial stewardship during a time of rapid antimicrobial development: Potential impact on industry for future investment

For The First Time, Scientists Have Caught Bacteria “Fishing” For DNA From Their Dead Friends

Global Expert Mission: UK-Germany Antimicrobial Resistance (AMR)

GARDP announces ‘5 BY 25’ goal in response to the growing burden of antibiotic resistant infections

Summary Paper AMR RESISTANCE SUMMIT Preventing an antibiotic apocalypse

JPIAMR Roadmap of Actions 2019-2024

Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia

Nabriva Therapeutics Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application for Lefamulin

David Braley Centre for Antibiotic Discovery gives researchers a fighting chance against antimicrobial resistance

UCL and UCLH to apply AI to tackle anti-microbial resistance

£2m to helps Leeds researchers fight anti-microbial resistance

Antibacterials in the pipeline and perspectives for the near future

Sustainable Discovery and Development of Antibiotics — Is a Nonprofit Approach the Future?

Rapid Analysis of Diagnostic and Antimicrobial Patterns in R (RadaR): Interactive Open-Source Software App for Infection Management and Antimicrobial Stewardship

‘Wonder technology’ to transform farming, food production and mitigate AMR pioneered by IGFS

The Wollongong Antimicrobial Resistance Research Alliance (WARRA)

New centre at McMaster University to tackle the antibiotic resistance crisis

Cannabidiol is a Powerful New Antibiotic

New commitments in the fight against antimicrobial resistance

Using open innovation and big data in the fight against antimicrobial resistance

Deadly Superbugs Win as Wall Street Flees Makers of Antibiotics

CARB-X AWARDS OXFORD DRUG DESIGN FUNDING TO DEVELOP A NEW CLASS OF ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE INFECTIONS

QIAGEN : to embrace global initiative to combat antibiotic resistance and launches cutting-edge QIAGEN Microbial Insights AR

Research aims to prevent resistance to staph infection treatment

Antibiotic resistance test for gonorrhea gets FDA breakthrough nod

Antibiotic Resistance in low- and middle-income countries and the prospect of Machine Learning approaches to fight against this threat

Antibiotic Produced by the Microbiome Kills Bacteria by Disturbing Energy Metabolism

Challenges in Antibiotic R&D Calling for a Global Strategy Considering Both Short- and Long-Term Solutions

DISARM Act Provides Framework Needed to Spur Antibiotic R&D, Protect Existing Drugs

Reinventing the antimicrobial pipeline in response to the global crisis of antimicrobial-resistant infections

AMR incentives could be next big EU opportunity, pharma boss says

Scientists Develop New Treatment Option for Multidrug-Resistant Infections

Now drug-resistant genes can be identified in less than half the time

Profiling the natural context of antibiotic resistance in microbial communities.

Close proximity interactions support transmission of ESBL-K. pneumoniae but not ESBL-E. coli in healthcare settings

Liver transplant baby saved by “trained” virus at Saint-Luc hospital

New compound which kills antibiotic-resistant superbugs discovered

New compound which kills antibiotic-resistant superbugs discovered

Civil War Era Plant-Based Medicines Attack Drug-Resistant Bacteria in Lab Tests

Scientists spy on superbugs to see how they outsmart our antibiotics

EMA facilitates early engagement with medicine developers to combat antimicrobial resistance

The extraordinary powers of bacteria visualized in real time

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed